- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00263861
Nerve Function in Older Diabetic Patients Who Are Undergoing Chemotherapy for Metastatic Solid Tumors
Impact of Treatment With Taxane or Platinum-Containing Regimens on Peripheral Nerve Functioning in Older Cancer Patients With Diabetes: An Exploratory Study
RATIONALE: Learning about the side effects of chemotherapy may help plan treatment and may help patients live more comfortably.
PURPOSE: This clinical trial is studying nerve function in older diabetic patients who are undergoing chemotherapy for metastatic solid tumors.
Panoramica dello studio
Stato
Intervento / Trattamento
Descrizione dettagliata
OBJECTIVES:
Primary
- Determine changes in peripheral nerve function in older patients with diabetes and metastatic solid tumors treated with taxane or platinum-containing chemotherapy regimens.
- Determine the extent to which age, pre-existing diabetes mellitus, and level of glycemic control predict a differential pattern in outcome beyond the effect of the drugs in patients treated with these regimens.
- Develop a clinical assessment that would predict whether or not patients with diabetes mellitus are more or less susceptible to the neurotoxic effects of chemotherapy.
OUTLINE: This is a longitudinal study.
Patients undergo an interview and clinical evaluation to measure demographic data, cutaneous sensation, gait and balance, vibration, lower extremity muscle strength, orthostatic blood pressure, and glycemic control. Patients are evaluated at baseline, every 3 weeks during chemotherapy for up to 4 treatments, and at 2 months after completion of treatment.
PROJECTED ACCRUAL: A total of 50 patients will be accrued for this study.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Ohio
-
Cleveland, Ohio, Stati Uniti, 44106-5047
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
DISEASE CHARACTERISTICS:
Diagnosis of solid tumor
- Metastatic disease (stage IV)
Planning neoadjuvant or adjuvant treatment of locoregional definitive or systemic therapy comprising ≥ 1 of the following:
- Taxane (paclitaxel or docetaxel)
- Platinum (cisplatin, carboplatin, or oxaliplatin)
- Diagnosis of type I or II diabetes mellitus
PATIENT CHARACTERISTICS:
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
Other
- No other disease that reduces peripheral nerve function (e.g., HIV/AIDS, uremia, spinal injuries, alcoholism, or CNS problems)
PRIOR CONCURRENT THERAPY:
Chemotherapy
- See Disease Characteristics
- No prior chemotherapy
- No prior or concurrent neurotoxic drugs (i.e., vincristine)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
---|---|
Cutaneous sensation as measured by Semmes-Weinstein monofilaments
Lasso di tempo: baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
Gait and balance as measured by Tinetti Performance Oriented Assessment of Gait and Balance Instrument
Lasso di tempo: baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
Vibration as measured by tuning fork
Lasso di tempo: baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
Lower extremity muscle strength as measured by Dynamometer
Lasso di tempo: baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
Blood pressure changes
Lasso di tempo: baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
Glycemic control as measured by Glycosylated Hemoglobin Assay
Lasso di tempo: baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Constance Visovsky, PhD, RN, ACNP, Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- CWRU6Z03
- P30CA043703 (Sovvenzione/contratto NIH degli Stati Uniti)
- CASE-CWRU-6Z03 (Altro identificatore: Case Comprehensive Cancer Center)
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su management of therapy complications
-
Vyaire MedicalNon ancora reclutamentoSindrome da insufficienza respiratoria del neonatoItalia